Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marijo Bilusic

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Canadian Journal of Urology|April 21, 2015
Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasisScott M Norberg, Michelle Oros, Varsha Manucha, et al.
Seminars in Oncology|May 19, 2012
Clinical evaluation of TRICOM vector therapeutic cancer vaccinesRavi A Madan, Marijo Bilusic, Christopher Heery, et al.
Human Vaccines & Immunotherapeutics|September 1, 2017
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinationsMargaret E Gatti-Mays, Jason M Redman, Julie M Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Recurrent bulbar paralysis caused by botulinum toxin type BMarijo Bilusic, Jean Pattathil, Michael Brescia, et al.
Urologic Oncology|November 7, 2017
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysisItalia Grenga, Renee N Donahue, Morgan L Gargulak, et al.
Journal for Immunotherapy of Cancer|December 20, 2018
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case reportCecilia Monge, Hoyoung Maeng, Alessandra Brofferio, et al.
The American Journal of Managed Care|April 19, 2018
Provider and patient burdens of obtaining oral anticancer medicationsDaniel M Geynisman, Caitlin R Meeker, Jamie L Doyle, et al.
JACC. Case Reports|June 3, 2026
Triple M Overlap Syndrome After Immune Checkpoint Inhibitors: A Case Series of a High-Mortality PhenotypeMaria F Osorio, Alekhya Mitta, Fabricio Malaguez-Webber, et al.
Frontiers in Oncology|December 17, 2020
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case ReportDanielle M Pastor, Katherine Lee-Wisdom, Andrew E Arai, et al.
The Urologic Clinics of North America|October 3, 2020
The Potential Role for Immunotherapy in Biochemically Recurrent Prostate CancerMarijo Bilusic, David J Einstein, Fatima H Karzai, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Canadian Journal of Urology|April 21, 2015
Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasisScott M Norberg, Michelle Oros, Varsha Manucha, et al.
Seminars in Oncology|May 19, 2012
Clinical evaluation of TRICOM vector therapeutic cancer vaccinesRavi A Madan, Marijo Bilusic, Christopher Heery, et al.
Human Vaccines & Immunotherapeutics|September 1, 2017
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinationsMargaret E Gatti-Mays, Jason M Redman, Julie M Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Recurrent bulbar paralysis caused by botulinum toxin type BMarijo Bilusic, Jean Pattathil, Michael Brescia, et al.
Urologic Oncology|November 7, 2017
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysisItalia Grenga, Renee N Donahue, Morgan L Gargulak, et al.
Journal for Immunotherapy of Cancer|December 20, 2018
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case reportCecilia Monge, Hoyoung Maeng, Alessandra Brofferio, et al.
The American Journal of Managed Care|April 19, 2018
Provider and patient burdens of obtaining oral anticancer medicationsDaniel M Geynisman, Caitlin R Meeker, Jamie L Doyle, et al.
JACC. Case Reports|June 3, 2026
Triple M Overlap Syndrome After Immune Checkpoint Inhibitors: A Case Series of a High-Mortality PhenotypeMaria F Osorio, Alekhya Mitta, Fabricio Malaguez-Webber, et al.
Frontiers in Oncology|December 17, 2020
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case ReportDanielle M Pastor, Katherine Lee-Wisdom, Andrew E Arai, et al.
The Urologic Clinics of North America|October 3, 2020
The Potential Role for Immunotherapy in Biochemically Recurrent Prostate CancerMarijo Bilusic, David J Einstein, Fatima H Karzai, et al.
Pageof 8